Pub Date : 2025-12-01DOI: 10.1097/01.ogx.0001176356.57234.17
Mario Preti, Fiona Lewis, Xavier Carcopino, Federica Bevilacqua, Laura Burney Ellis, Pia Halonen, Reda Hemida, Robert Jach, Vesna Kesic, Maria Kyrgiou, Tiziano Maggino, Amélia Pedro, Denis Querleu, Colleen Stockdale, Nadja Taumberger, Bilal Esat Temiz, Pedro Vieira-Baptista, Murat Gultekin
(Abstracted from Int J Gynecol Cancer 2025;35(1):100007, doi:10.1016/j.ijgc.2024.100007) At the time of screening for cervical cancer, an external inspection of genitalia is a standard part of the procedure. This is in part due to inspection for signs of vulvar cancer, but evidence suggests that enough attention is not paid to this inspection as early diagnosis of vulvar cancer is still an issue.
{"title":"Vulvar Inspection at the Time of Cervical Cancer Screening: European Society of Gynecological Oncology (ESGO), International Society for the Study of Vulvovaginal Disease (ISSVD), European College for the Study of Vulval Disease (ECSVD), and European Federation for Colposcopy (EFC) Consensus Statements.","authors":"Mario Preti, Fiona Lewis, Xavier Carcopino, Federica Bevilacqua, Laura Burney Ellis, Pia Halonen, Reda Hemida, Robert Jach, Vesna Kesic, Maria Kyrgiou, Tiziano Maggino, Amélia Pedro, Denis Querleu, Colleen Stockdale, Nadja Taumberger, Bilal Esat Temiz, Pedro Vieira-Baptista, Murat Gultekin","doi":"10.1097/01.ogx.0001176356.57234.17","DOIUrl":"10.1097/01.ogx.0001176356.57234.17","url":null,"abstract":"<p><p>(Abstracted from Int J Gynecol Cancer 2025;35(1):100007, doi:10.1016/j.ijgc.2024.100007) At the time of screening for cervical cancer, an external inspection of genitalia is a standard part of the procedure. This is in part due to inspection for signs of vulvar cancer, but evidence suggests that enough attention is not paid to this inspection as early diagnosis of vulvar cancer is still an issue.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"80 12","pages":"759-761"},"PeriodicalIF":3.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145857611","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01DOI: 10.1097/01.ogx.0001176336.07664.a1
Nansi S Boghossian, Lucy T Greenberg, Erika M Edwards, Jeffrey D Horbar
(Abstracted from JAMA 2025;333(21):1925-1928) Restrictive abortion policies in many states may raise ethical and clinical considerations among neonatologists, who feel obligated to attempt life support to infants, regardless of the prognosis. Studies that have evaluated trends in initiating active treatment and the survival rate of infants born between 22 and 25 weeks of gestation are scarce.
{"title":"Active Treatment and Survival Trends for Periviable Births by Race and Ethnicity.","authors":"Nansi S Boghossian, Lucy T Greenberg, Erika M Edwards, Jeffrey D Horbar","doi":"10.1097/01.ogx.0001176336.07664.a1","DOIUrl":"10.1097/01.ogx.0001176336.07664.a1","url":null,"abstract":"<p><p>(Abstracted from JAMA 2025;333(21):1925-1928) Restrictive abortion policies in many states may raise ethical and clinical considerations among neonatologists, who feel obligated to attempt life support to infants, regardless of the prognosis. Studies that have evaluated trends in initiating active treatment and the survival rate of infants born between 22 and 25 weeks of gestation are scarce.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"80 12","pages":"737-738"},"PeriodicalIF":3.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145857637","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01DOI: 10.1097/01.ogx.0001176360.66303.ab
Christopher M Morosky, Laura Baecher-Lind, Katherine T Chen, Angela Fleming, Shireen Madani Sims, Helen Kang Morgan, Celeste S Royce, Tammy Sonn, Alyssa Stephenson-Famy, Jill Sutton, Jonathan Schaffir, Rashmi Bhargava
(Abstracted from Am J Obstet Gynecol 2025;233(1):4-11) Artificial intelligence (AI) chatbots are rising in popularity as new developments increase their abilities and accuracy; their function includes using large language models to generate responses based on history. The use of AI in clinical practice and medical education includes radiology imaging assessment, clinical decision support tools for diagnosis and treatment recommendations, and the potential for the enhancement of teaching, learning, and assessment in medical education.
{"title":"Practical Applications of Artificial Intelligence Chatbots in Obstetrics and Gynecology Medical Education.","authors":"Christopher M Morosky, Laura Baecher-Lind, Katherine T Chen, Angela Fleming, Shireen Madani Sims, Helen Kang Morgan, Celeste S Royce, Tammy Sonn, Alyssa Stephenson-Famy, Jill Sutton, Jonathan Schaffir, Rashmi Bhargava","doi":"10.1097/01.ogx.0001176360.66303.ab","DOIUrl":"https://doi.org/10.1097/01.ogx.0001176360.66303.ab","url":null,"abstract":"<p><p>(Abstracted from Am J Obstet Gynecol 2025;233(1):4-11) Artificial intelligence (AI) chatbots are rising in popularity as new developments increase their abilities and accuracy; their function includes using large language models to generate responses based on history. The use of AI in clinical practice and medical education includes radiology imaging assessment, clinical decision support tools for diagnosis and treatment recommendations, and the potential for the enhancement of teaching, learning, and assessment in medical education.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"80 12","pages":"761-762"},"PeriodicalIF":3.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145724913","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01DOI: 10.1097/01.ogx.0001176356.57234.17
Mario Preti, Fiona Lewis, Xavier Carcopino, Federica Bevilacqua, Laura Burney Ellis, Pia Halonen, Reda Hemida, Robert Jach, Vesna Kesic, Maria Kyrgiou, Tiziano Maggino, Amélia Pedro, Denis Querleu, Colleen Stockdale, Nadja Taumberger, Bilal Esat Temiz, Pedro Vieira-Baptista, Murat Gultekin
(Abstracted from Int J Gynecol Cancer 2025;35(1):100007, doi:10.1016/j.ijgc.2024.100007) At the time of screening for cervical cancer, an external inspection of genitalia is a standard part of the procedure. This is in part due to inspection for signs of vulvar cancer, but evidence suggests that enough attention is not paid to this inspection as early diagnosis of vulvar cancer is still an issue.
{"title":"Vulvar Inspection at the Time of Cervical Cancer Screening: European Society of Gynecological Oncology (ESGO), International Society for the Study of Vulvovaginal Disease (ISSVD), European College for the Study of Vulval Disease (ECSVD), and European Federation for Colposcopy (EFC) Consensus Statements.","authors":"Mario Preti, Fiona Lewis, Xavier Carcopino, Federica Bevilacqua, Laura Burney Ellis, Pia Halonen, Reda Hemida, Robert Jach, Vesna Kesic, Maria Kyrgiou, Tiziano Maggino, Amélia Pedro, Denis Querleu, Colleen Stockdale, Nadja Taumberger, Bilal Esat Temiz, Pedro Vieira-Baptista, Murat Gultekin","doi":"10.1097/01.ogx.0001176356.57234.17","DOIUrl":"https://doi.org/10.1097/01.ogx.0001176356.57234.17","url":null,"abstract":"<p><p>(Abstracted from Int J Gynecol Cancer 2025;35(1):100007, doi:10.1016/j.ijgc.2024.100007) At the time of screening for cervical cancer, an external inspection of genitalia is a standard part of the procedure. This is in part due to inspection for signs of vulvar cancer, but evidence suggests that enough attention is not paid to this inspection as early diagnosis of vulvar cancer is still an issue.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"80 12","pages":"759-761"},"PeriodicalIF":3.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145724925","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01DOI: 10.1097/01.ogx.0001176364.53087.c6
Anjeza Xholli, Francesca Oppedisano, Mattia Francesco Ferraro, Isabella Perugi, Ambrogio P Londero, Angelo Cagnacci
(Abstracted from Contraception 2025:150:111016, doi:10.1016/j.contraception.2025.111016) Adenomyosis occurs when ectopic endometrial glands invade the myometrium and can cause symptoms such as an enlarged uterus, heavy menstrual bleeding, pelvic pain, infertility, and pregnancy complications. It occurs in an estimated 20% of asymptomatic and 45% of symptomatic women, and risk factors for its development include age, endometriosis, multiple births, uterine surgery, spontaneous miscarriage, and cervical conditions.
{"title":"Vaginal Contraception With NuvaRing Decreases Symptoms and Uterine Features of Adenomyosis: A Prospective Evaluation.","authors":"Anjeza Xholli, Francesca Oppedisano, Mattia Francesco Ferraro, Isabella Perugi, Ambrogio P Londero, Angelo Cagnacci","doi":"10.1097/01.ogx.0001176364.53087.c6","DOIUrl":"https://doi.org/10.1097/01.ogx.0001176364.53087.c6","url":null,"abstract":"<p><p>(Abstracted from Contraception 2025:150:111016, doi:10.1016/j.contraception.2025.111016) Adenomyosis occurs when ectopic endometrial glands invade the myometrium and can cause symptoms such as an enlarged uterus, heavy menstrual bleeding, pelvic pain, infertility, and pregnancy complications. It occurs in an estimated 20% of asymptomatic and 45% of symptomatic women, and risk factors for its development include age, endometriosis, multiple births, uterine surgery, spontaneous miscarriage, and cervical conditions.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"80 12","pages":"763-764"},"PeriodicalIF":3.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145724984","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01DOI: 10.1097/OGX.0000000000001450
Aikaterini Raptopoulou, Eirini Boureka, Anastasios Liberis, Georgios Michos, Ioannis Kalogiannidis, Apostolos Mamopoulos, Ioannis Tsakiridis, Themistoklis Dagklis
Importance: Cytomegalovirus (CMV) infection in pregnancy is the most common viral cause of congenital infection and is associated with serious sequelae.
Objectives: This study aimed to review and compare the recommendations from published guidelines on screening, diagnosis, and management prevention of CMV infection during pregnancy, as well as neonatal management.
Evidence acquisition: A descriptive review of guidelines from the Society for Maternal-Fetal Medicine, the Royal College of Obstetricians & Gynecologists, the Royal Australian and New Zealand College of Obstetricians and Gynecologists, the Society of Obstetricians and Gynecologists of Canada, and the European Congenital Infection Initiative (ECCI) on CMV infection in pregnancy was conducted.
Results: There is a consensus on the importance of prevention, whereas all guidelines underline that the severity of fetal infection results mainly from primary maternal infection occurring during the early periconceptional period or first trimester of pregnancy. Controversy exists regarding universal screening for CMV, with the Society for Maternal-Fetal Medicine, the Royal College of Obstetricians & Gynecologists, and the Royal Australian and New Zealand College of Obstetricians and Gynecologists stating against it, the Society of Obstetricians and Gynecologists of Canada recommending testing for CMV early for women at high-risk only in areas where avidity testing is available, and ECCI recommending routine screening up to 16 weeks of pregnancy. Moreover, there is relative consensus on the diagnosis of maternal infection, either with CMV immunoglobulin G seroconversion or with positive immunoglobulin M CMV in combination with low immunoglobulin G avidity, with ECCI recommending only the latter. Moreover, there is a disagreement among the reviewed guidelines on the antenatal management of maternal and fetal infection, whereas ECCI offers the most comprehensive recommendations in neonatal management compared with the other guidelines.
Conclusions: CMV infection in pregnancy is considered a major contributor to severe neurodevelopmental disability and hearing impairment in infants. Hence, consistent global guidelines should be issued to be integrated into everyday practice to achieve the optimal perinatal outcome.
Target audience: Obstetricians and gynecologists, family physicians.
Cme learning objectives: After participating in this activity, the learner should be better able to discuss hygiene strategies for the prevention of maternal infection from CMV; describe diagnostic methods for maternal CMV infection; and explain the optimal management of pregnant women with CMV infection.
{"title":"Cytomegalovirus Infection in Pregnancy: A Comparative Review of Guidelines.","authors":"Aikaterini Raptopoulou, Eirini Boureka, Anastasios Liberis, Georgios Michos, Ioannis Kalogiannidis, Apostolos Mamopoulos, Ioannis Tsakiridis, Themistoklis Dagklis","doi":"10.1097/OGX.0000000000001450","DOIUrl":"https://doi.org/10.1097/OGX.0000000000001450","url":null,"abstract":"<p><strong>Importance: </strong>Cytomegalovirus (CMV) infection in pregnancy is the most common viral cause of congenital infection and is associated with serious sequelae.</p><p><strong>Objectives: </strong>This study aimed to review and compare the recommendations from published guidelines on screening, diagnosis, and management prevention of CMV infection during pregnancy, as well as neonatal management.</p><p><strong>Evidence acquisition: </strong>A descriptive review of guidelines from the Society for Maternal-Fetal Medicine, the Royal College of Obstetricians & Gynecologists, the Royal Australian and New Zealand College of Obstetricians and Gynecologists, the Society of Obstetricians and Gynecologists of Canada, and the European Congenital Infection Initiative (ECCI) on CMV infection in pregnancy was conducted.</p><p><strong>Results: </strong>There is a consensus on the importance of prevention, whereas all guidelines underline that the severity of fetal infection results mainly from primary maternal infection occurring during the early periconceptional period or first trimester of pregnancy. Controversy exists regarding universal screening for CMV, with the Society for Maternal-Fetal Medicine, the Royal College of Obstetricians & Gynecologists, and the Royal Australian and New Zealand College of Obstetricians and Gynecologists stating against it, the Society of Obstetricians and Gynecologists of Canada recommending testing for CMV early for women at high-risk only in areas where avidity testing is available, and ECCI recommending routine screening up to 16 weeks of pregnancy. Moreover, there is relative consensus on the diagnosis of maternal infection, either with CMV immunoglobulin G seroconversion or with positive immunoglobulin M CMV in combination with low immunoglobulin G avidity, with ECCI recommending only the latter. Moreover, there is a disagreement among the reviewed guidelines on the antenatal management of maternal and fetal infection, whereas ECCI offers the most comprehensive recommendations in neonatal management compared with the other guidelines.</p><p><strong>Conclusions: </strong>CMV infection in pregnancy is considered a major contributor to severe neurodevelopmental disability and hearing impairment in infants. Hence, consistent global guidelines should be issued to be integrated into everyday practice to achieve the optimal perinatal outcome.</p><p><strong>Target audience: </strong>Obstetricians and gynecologists, family physicians.</p><p><strong>Cme learning objectives: </strong>After participating in this activity, the learner should be better able to discuss hygiene strategies for the prevention of maternal infection from CMV; describe diagnostic methods for maternal CMV infection; and explain the optimal management of pregnant women with CMV infection.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"80 12","pages":"769-781"},"PeriodicalIF":3.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145724983","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01DOI: 10.1097/OGX.0000000000001474
Andrew P Fennell, Tony Roscioli, Michael Buckley, Ari E Horton, Sarah Long, Pramod Pharande, Luisa M Clucas
(Abstracted from N Engl J Med 2025;393(1), doi:10.1056/NEJMc2506080) Congenital thrombotic thrombocytopenic purpura (TTP) is a rare thrombotic microangiopathy caused by deficiency of the ADAMTS13 protein. Without a functional version of this enzyme, ultralarge von Willebrand factors accumulate inside small vessels, leading to early-onset, potentially life-threatening complications including hemolytic anemia, thrombocytopenia, and end-organ damage.
{"title":"Lifesaving Diagnosis Through Prenatal Genomic Sequencing.","authors":"Andrew P Fennell, Tony Roscioli, Michael Buckley, Ari E Horton, Sarah Long, Pramod Pharande, Luisa M Clucas","doi":"10.1097/OGX.0000000000001474","DOIUrl":"10.1097/OGX.0000000000001474","url":null,"abstract":"<p><p>(Abstracted from N Engl J Med 2025;393(1), doi:10.1056/NEJMc2506080) Congenital thrombotic thrombocytopenic purpura (TTP) is a rare thrombotic microangiopathy caused by deficiency of the ADAMTS13 protein. Without a functional version of this enzyme, ultralarge von Willebrand factors accumulate inside small vessels, leading to early-onset, potentially life-threatening complications including hemolytic anemia, thrombocytopenia, and end-organ damage.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"80 12","pages":"745-747"},"PeriodicalIF":3.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145724907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01DOI: 10.1097/01.ogx.0001176348.68652.62
(Abstracted from JAMA 2025;333(22):2006-2012) The US Preventive Services Task Force (USPSTF) has reaffirmed its recommendation for universal screening for syphilis in asymptomatic, pregnant adolescent and adult women early in pregnancy or at the first available opportunity. Through a reaffirmation process that considered whether new evidence warranted a change to its 2018 recommendation, the USPSTF concluded with high certainty that the recommendation has a "substantial net benefit."
{"title":"Screening for Syphilis Infection During Pregnancy: US Preventive Services Task Force Reaffirmation Recommendation Statement.","authors":"","doi":"10.1097/01.ogx.0001176348.68652.62","DOIUrl":"https://doi.org/10.1097/01.ogx.0001176348.68652.62","url":null,"abstract":"<p><p>(Abstracted from JAMA 2025;333(22):2006-2012) The US Preventive Services Task Force (USPSTF) has reaffirmed its recommendation for universal screening for syphilis in asymptomatic, pregnant adolescent and adult women early in pregnancy or at the first available opportunity. Through a reaffirmation process that considered whether new evidence warranted a change to its 2018 recommendation, the USPSTF concluded with high certainty that the recommendation has a \"substantial net benefit.\"</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"80 12","pages":"747-749"},"PeriodicalIF":3.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145724975","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01DOI: 10.1097/OGX.0000000000001477
Aneesha Cheedalla, Alyssa Thompson, Emily Fortman, Jennifer L Grasch, Kartik K Venkatesh, Mark B Landon, Heather A Frey
(Abstracted from Am J Obstet Gynecol 2025;232:570.e1-570.e7) Shoulder dystocia occurs in up to 3% of deliveries. Adverse neonatal outcomes from shoulder dystocia include brachial plexus injuries, humeral and clavicular fractures, and, in rare cases, hypoxic ischemic encephalopathy, seizures, and death.
{"title":"Maternal Body Mass Index, Maneuvers, and Neonatal Morbidity Associated With Shoulder Dystocia.","authors":"Aneesha Cheedalla, Alyssa Thompson, Emily Fortman, Jennifer L Grasch, Kartik K Venkatesh, Mark B Landon, Heather A Frey","doi":"10.1097/OGX.0000000000001477","DOIUrl":"10.1097/OGX.0000000000001477","url":null,"abstract":"<p><p>(Abstracted from Am J Obstet Gynecol 2025;232:570.e1-570.e7) Shoulder dystocia occurs in up to 3% of deliveries. Adverse neonatal outcomes from shoulder dystocia include brachial plexus injuries, humeral and clavicular fractures, and, in rare cases, hypoxic ischemic encephalopathy, seizures, and death.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"80 12","pages":"735-736"},"PeriodicalIF":3.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145857583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01DOI: 10.1097/OGX.0000000000001475
Cathalijne C B Post, Stephanie M de Boer, Melanie E Powell, Linda Mileshkin, Dionyssios Katsaros, Paul Bessette, Alexandra Leary, Petronella B Ottevanger, Mary McCormack, Pearly Khaw, Romerai D'Amico, Anthony Fyles, Cyrus Chargari, Henry C Kitchener, Viet Do, Andrea Lissoni, Diane Procencher, Catherine Genestrie, Hans W Nijman, Karen Whitmarsh, Ina M Jürgenliemk-Schulz, Amanda Feeney, Ludy C H W Lutgens, Jeanette Bouma, Alicia Leon-Castillo, Remi A Nout, Hein Putter, Tjalling Bosse, Carien L Creutzberg
(Abstracted from Lancet Oncol 2025;26(10):1370-1381) Fifteen percent to 20% of endometrial cancer patients have a high-risk form of the disease; this classification indicates a higher risk of cancer recurrence and cancer-related death. The standard therapy for high-risk endometrial cancer is pelvic radiotherapy.
{"title":"Adjuvant Chemoradiotherapy Versus Radiotherapy Alone in Women With High-Risk Endometrial Cancer (PORTEC-3): 10-Year Clinical Outcomes and Post Hoc Analysis by Molecular Classification From a Randomized Phase 3 Trial.","authors":"Cathalijne C B Post, Stephanie M de Boer, Melanie E Powell, Linda Mileshkin, Dionyssios Katsaros, Paul Bessette, Alexandra Leary, Petronella B Ottevanger, Mary McCormack, Pearly Khaw, Romerai D'Amico, Anthony Fyles, Cyrus Chargari, Henry C Kitchener, Viet Do, Andrea Lissoni, Diane Procencher, Catherine Genestrie, Hans W Nijman, Karen Whitmarsh, Ina M Jürgenliemk-Schulz, Amanda Feeney, Ludy C H W Lutgens, Jeanette Bouma, Alicia Leon-Castillo, Remi A Nout, Hein Putter, Tjalling Bosse, Carien L Creutzberg","doi":"10.1097/OGX.0000000000001475","DOIUrl":"10.1097/OGX.0000000000001475","url":null,"abstract":"<p><p>(Abstracted from Lancet Oncol 2025;26(10):1370-1381) Fifteen percent to 20% of endometrial cancer patients have a high-risk form of the disease; this classification indicates a higher risk of cancer recurrence and cancer-related death. The standard therapy for high-risk endometrial cancer is pelvic radiotherapy.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"80 12","pages":"757-759"},"PeriodicalIF":3.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145724813","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}